India Infoline News Service | Mumbai December 15, 2014 11:19 IST
Report said that Shaw met Andhra Pradesh Chief Minister N. Chandrababu Naidu and informed him of the companys plans to set up a unit in Visakhapatnam.
Business Wire | November 20, 2014 22:38 IST
Biocon Q2 FY15 Revenues at Rs 773 Crore, PAT at Rs 102 Crore
Business Wire | November 20, 2014 21:12 IST
Biocon Expands its Strategic Partnership with CytoSorbents for CytoSorb to Treat SIRS and Cardiac Surgery Patients
capital market | Mumbai November 04, 2014 16:02 IST
capital market | Mumbai October 27, 2014 10:49 IST
capital market | Mumbai October 22, 2014 11:23 IST
Biocon fell 1.39% to Rs 473.10 at 11:12 IST on BSE after consolidated net profit fell 0.1% to Rs 102.05 crore on 2.7% rise in total income to Rs 772.63 crore in Q2 September 2014 over Q2 September 2013.
capital market | Mumbai October 22, 2014 11:01 IST
Sales rise 2.11% to Rs 749.69 crore
capital market | Mumbai October 22, 2014 11:00 IST
Sales rise 0.86% to Rs 538.78 crore
India Infoline News Service | Mumbai October 22, 2014 09:45 IST
The stock has slipped over 3 per cent on the BSE.
India Infoline News Service | Mumbai October 22, 2014 08:23 IST
Total Income has increased from Rs. 7525.40 mn for the quarter ended September 30, 2013 to Rs. 7726.30 mn for the quarter ended September 30, 2014.
India Infoline Research Team | Mumbai October 07, 2014 15:47 IST
Biocon is looking to move up the value chain from APIs to finished dosages and has forayed in to the US generics market with its first set of ANDAs filings.
capital market | Mumbai October 01, 2014 12:38 IST
On 21 October 2014
capital market | Mumbai October 01, 2014 00:00 IST
Biocon will hold a meeting of the Board of Directors of the Company on 21 October 2014, to approve and take on record the unaudited financial results of the Company for the quarter and half year ended 30 September 2014 (Q2).
India Infoline News Service | Mumbai September 19, 2014 09:53 IST
The stock has hit a high of Rs514 and a low of Rs506.
capital market | Mumbai September 19, 2014 09:23 IST
Biocon rose 2.31% to Rs 511.50 at 9:25 IST on BSE after the company said it sold a 10% stake in its research services arm, Syngene International, to Silver Leaf Oak (Mauritius) for Rs 380 crore.
capital market | Mumbai September 19, 2014 00:00 IST
Biocon Limited has informed the Exchange regarding a press release dated Sept. 18, 2014 titled Silver Leaf Oak acquires 10% stake in Syngene International, Biocon's Research Services Subsidiary.
capital market | Mumbai September 18, 2014 18:05 IST
Silver Leaf to acquire 10% stake in Syngene International
capital market | Mumbai September 18, 2014 00:00 IST
Biocon announced that Silver Leaf Oak (Mauritius), an investment vehicle advised by India Value Fund Advisors (IVFA) has agreed to acquire a minority 10% stake in Syngene International, Biocon's Research Services subsidiary. <p>Silver Leaf will acquire the stake from Biocon Research, a wholly owned subsidiary of Biocon at a valuation of Rs 3800 crore. Post completion of this transaction, Biocon and BRL will jointly hold 85.54% stake in Syngene.
capital market | Mumbai September 11, 2014 13:50 IST
Biocon fell 1.87% to Rs 494.60 at 13:50 IST on BSE on profit booking after the stock rose 8.45% in the preceding eight trading sessions to Rs 504 on 10 September 2014, from a recent low of Rs 464.75 on 28 August 2014.
India Infoline News Service / 11:47, Dec 12, 2014
Stepping into a new life comes with a multitude of responsibilities Therefore, it is important to include your spouse in your monetary affairs at the earliest in order to be on common grounds financially.